Stocks
Anika Therapeutics (ANIK) Debt/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2023 | 2023 | LTM ? | |||
| Debt/EBITDA | -28.7 | 11.3 | 2.50 | -17.4 | 3.91 | 0.69 | ||
| Changes by years, y/y, % | -123% | -139% | -78% | -797% | -122% | |||
Anika Therapeutics. Debt/EBITDA
Anika Therapeutics. Debt/EBITDA, changes, %
Anika Therapeutics (ANIK) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 5.33 | 9.79 | 19.3 | 2.62 | 1.51 | 0.69 | ||
| Changes by years, y/y, % | +52% | +393% | +1 080% | +20% | -31% | |||
| Changes by quarters, q/q, % | +37% | +84% | +97% | -86% | -42% | |||
